Lou is an innovator with 25 years of experience in biotech/life science development, artificial intelligence, venture equity, and branding/media design. Lou received a B.A. in English Literature in 1983 from Princeton University, where he was a University Scholar, ran the Film Society and received the Ward Mathis prize.

Lou is a passionate science and technology entrepreneur, with dozens of patents and patents pending. He is the CEO of NaNotics, LLC, which is developing a new nano-medical platform called "NaNots" – which are immune modulating nano-scavengers, which Lou invented and patented. NaNotics has raised a $8.75m to date and is currently building NaNots against cancer, sepsis, autoimmune disease and aging.

Before founding NaNotics, Lou worked for over 10 years with Dr. John Sperling, founder of the University of Phoenix, leading various scientific companies & projects on Sperling’s behalf, including development of commercial cloning capabilities for cat, dog and other species. Lou also served on Sperling's "Greenlight Committee", reviewing $1b in equity investment proposals and approving over $100m, primarily for longevity and oncology research.